Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Relief Therapeutics Hldg Ag (OP: RLFTF ) 7.285 +2.375 (+48.37%) Streaming Delayed Price Updated: 3:56 PM EDT, Oct 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 21,921 Open 6.900 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 4.910 Today's Range 6.900 - 7.450 52wk Range 1.100 - 4.980 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa October 07, 2024 Via ACCESSWIRE Relief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for Phenylketonuria October 03, 2024 Via ACCESSWIRE Performance YTD +199.79% +199.79% 1 Month +158.44% +158.44% 3 Month +502.07% +502.07% 6 Month +402.41% +402.41% 1 Year +210.00% +210.00% More News Read More Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 September 17, 2024 Via ACCESSWIRE Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024 September 01, 2024 Via ACCESSWIRE Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update August 29, 2024 Via ACCESSWIRE Relief Therapeutics Secures up to $11 Million from Royalty Sales August 04, 2024 Via ACCESSWIRE RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting April 26, 2024 Via ACCESSWIRE RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting June 27, 2024 Via ACCESSWIRE Relief Therapeutics Announces Executive Changes June 03, 2024 Via ACCESSWIRE Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders May 29, 2024 Via ACCESSWIRE Relief Therapeutics Announces New Executive Leadership Team Strengthening Capabilities to Guide the Company through Pipeline Development Initiatives May 07, 2024 Via ACCESSWIRE Relief Therapeutics has Published its Annual Report April 29, 2024 Via ACCESSWIRE Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria March 22, 2024 From Eton Pharmaceuticals Via GlobeNewswire Relief Therapeutics Renews CHF 50 million Share Subscription Facility February 27, 2024 Via ACCESSWIRE Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth December 05, 2023 Via ACCESSWIRE Relief Therapeutics Announces CEO Transition November 22, 2023 Via ACCESSWIRE Relief Therapeutics Announces that more than 400,000 of its ADRs are Currently Outstanding and that, as a Result, the Company has Achieved an Important NASDAQ Initial Listing Milestone October 10, 2023 Via ACCESSWIRE Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference September 01, 2023 Via ACCESSWIRE Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE(R) in the U.S. with Pentec Health July 19, 2023 Via ACCESSWIRE Relief Therapeutics Announces Swissmedic Approval and Operation of New Good Manufacturing Practice-Compliant Laboratory May 15, 2023 Via ACCESSWIRE Relief Therapeutics Has Filed its 2022 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission May 12, 2023 Via ACCESSWIRE Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares May 03, 2023 Via ACCESSWIRE Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule May 01, 2023 Via ACCESSWIRE Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders April 28, 2023 Via ACCESSWIRE Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100 April 17, 2023 Via ACCESSWIRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
